These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 8185199

  • 1. Role of CCK in the regulation of dynamic and tonic mechanical response of the human gastric fundus to lipids.
    Mesquita MA, Thompson DG, Ahluwalia NK, Troncon LE, D'Amato M, Rovati LC.
    Ann N Y Acad Sci; 1994 Mar 23; 713():393-4. PubMed ID: 8185199
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of dietary fat on postprandial gastrointestinal motility are inhibited by a cholecystokinin type A receptor antagonist.
    De Giorgio R, Stanghellini V, Ricci Maccarini M, Morselli-Labate AM, Barbara G, Franzoso L, Rovati LC, Corinaldesi R, Barbara L, Go VL.
    Ann N Y Acad Sci; 1994 Mar 23; 713():226-31. PubMed ID: 8185163
    [No Abstract] [Full Text] [Related]

  • 4. Endogenous cholecystokinin in postprandial lower esophageal sphincter function and fundic tone in humans.
    Zerbib F, Bruley Des Varannes S, Scarpignato C, Leray V, D'Amato M, Rozé C, Galmiche JP.
    Am J Physiol; 1998 Dec 23; 275(6):G1266-73. PubMed ID: 9843762
    [Abstract] [Full Text] [Related]

  • 5. CCK-A antagonists: which and how.
    D'Amato M, Rovati LC.
    Eur J Clin Invest; 1995 Mar 23; 25(3):213-4. PubMed ID: 7781670
    [No Abstract] [Full Text] [Related]

  • 6. Cholecystokinin-A receptors modulate gastric sensory and motor responses to gastric distension and duodenal lipid.
    Feinle C, D'Amato M, Read NW.
    Gastroenterology; 1996 May 23; 110(5):1379-85. PubMed ID: 8613041
    [Abstract] [Full Text] [Related]

  • 7. Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide.
    Lieverse RJ, Jansen JB, Masclee AA, Rovati LC, Lamers CB.
    Gut; 1994 Apr 23; 35(4):501-5. PubMed ID: 8174988
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of food intake in response to intestinal lipid is mediated by cholecystokinin in humans.
    Matzinger D, Gutzwiller JP, Drewe J, Orban A, Engel R, D'Amato M, Rovati L, Beglinger C.
    Am J Physiol; 1999 Dec 23; 277(6):R1718-24. PubMed ID: 10600919
    [Abstract] [Full Text] [Related]

  • 9. Inhibitory action of CCK-OP on rat proximal colon.
    Kishimoto S, Machino H, Kobayashi H, Haruma K, Kajiyama G, Miyoshi A, Fujii K.
    Ann N Y Acad Sci; 1994 Mar 23; 713():407-9. PubMed ID: 7910443
    [No Abstract] [Full Text] [Related]

  • 10. Role of cholecystokinin in pancreatic exocrine response to intraluminal amino acids and fat.
    Stubbs RS, Stabile BE.
    Am J Physiol; 1985 Mar 23; 248(3 Pt 1):G347-52. PubMed ID: 2858160
    [Abstract] [Full Text] [Related]

  • 11. Role of cholecystokinin in the regulation of satiation and satiety in humans.
    Lieverse RJ, Jansen JB, Masclee AA, Lamers CB.
    Ann N Y Acad Sci; 1994 Mar 23; 713():268-72. PubMed ID: 8185168
    [No Abstract] [Full Text] [Related]

  • 12. Endogenous CCK in the control of gastric secretory response to meal in normal subjects and duodenal ulcer patients.
    Konturek JW, Stoll R, Domschke W, Konturek SJ.
    Ann N Y Acad Sci; 1994 Mar 23; 713():442-5. PubMed ID: 8185212
    [No Abstract] [Full Text] [Related]

  • 13. Role of nitric oxide in fasting gastric fundus tone and in 5-HT1 receptor-mediated relaxation of gastric fundus.
    Coulie B, Tack J, Sifrim D, Andrioli A, Janssens J.
    Am J Physiol; 1999 Feb 23; 276(2):G373-7. PubMed ID: 9950810
    [Abstract] [Full Text] [Related]

  • 14. [Effect of cholecystokinin and its antagonists lorglumide, devazepide, and L-365,260 on gastrointestinal motility in rats].
    Wang SX.
    Zhongguo Yao Li Xue Bao; 1993 Sep 23; 14(5):443-6. PubMed ID: 8010038
    [Abstract] [Full Text] [Related]

  • 15. Properties of receptors for gastrin and CCK on gastric smooth muscle cells.
    Menozzi D, Gardner JD, Jensen RT, Maton PN.
    Am J Physiol; 1989 Jul 23; 257(1 Pt 1):G73-9. PubMed ID: 2473654
    [Abstract] [Full Text] [Related]

  • 16. Clinical efficacy and prokinetic effect of the CCK-A antagonist loxiglumide in nonulcer dyspepsia.
    Chua AS, Bekkering M, Rovati LC, Keeling PW.
    Ann N Y Acad Sci; 1994 Mar 23; 713():451-3. PubMed ID: 8185214
    [No Abstract] [Full Text] [Related]

  • 17. Cholecystokinin in transient lower oesophageal sphincter relaxation due to gastric distension in humans.
    Boulant J, Mathieu S, D'Amato M, Abergel A, Dapoigny M, Bommelaer G.
    Gut; 1997 May 23; 40(5):575-81. PubMed ID: 9203932
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.